Triumvira Immunologics Inc.
$74,900.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2018-2019
Canada
Triumvira Immunologics has developed a potent new personalized cell therapy for cancer. The personalized nature of the product is a major driver of cost and can delay patient access. In this project,...